Antiretroviral therapy coverage for PMTCT in Mauritania

Mauritania: Antiretroviral therapy coverage for PMTCT was 39.0% in 2024. ◆ Volatile

Latest (2024)
39.0%
Change on year
down 2.5%
World rank
73rd
of 84 countries
All-time high
63.0%
in 2014
All-time low
0.0%
in 2000
Years of data
25
2000–2024

Antiretroviral therapy coverage for PMTCT in Mauritania, 2000–2024

02040602000201220242000: 0 % of pregnant women living with HIV2001: 0 % of pregnant women living with HIV2002: 0 % of pregnant women living with HIV2003: 0 % of pregnant women living with HIV2004: 0 % of pregnant women living with HIV2005: 0 % of pregnant women living with HIV2006: 1 % of pregnant women living with HIV2007: 6 % of pregnant women living with HIV2008: 5 % of pregnant women living with HIV2009: 8 % of pregnant women living with HIV2010: 8 % of pregnant women living with HIV2011: 9 % of pregnant women living with HIV2012: 4 % of pregnant women living with HIV2013: 10 % of pregnant women living with HIV2014: 63 % of pregnant women living with HIV2015: 60 % of pregnant women living with HIV2016: 19 % of pregnant women living with HIV2017: 14 % of pregnant women living with HIV2018: 23 % of pregnant women living with HIV2019: 41 % of pregnant women living with HIV2020: 25 % of pregnant women living with HIV2021: 9 % of pregnant women living with HIV2022: 29 % of pregnant women living with HIV2023: 40 % of pregnant women living with HIV2024: 39 % of pregnant women living with HIV

Source: UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Measured in % of pregnant women living with HIV.

Analysis

Mauritania recorded 39.0% for antiretroviral therapy coverage for pmtct in 2024.

Compared with earlier readings it is down 2.5% on the previous year and down 38.1% over ten years.

Over the whole period, antiretroviral therapy coverage for pmtct in Mauritania peaked at 63.0% in 2014 and was at its lowest, 0.0%, in 2000.

That places Mauritania 73rd out of 84 countries with data for 2024, putting it in the bottom quarter.

The series is highly variable year to year, so single readings are best treated with caution.

Antiretroviral therapy coverage for PMTCT in Mauritania, year by year

Annual values for Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV) in Mauritania, 2000 to 2024.
Year % of pregnant women living with HIV Change
2000 0.0%
2001 0.0%
2002 0.0%
2003 0.0%
2004 0.0%
2005 0.0%
2006 1.0%
2007 6.0% +500.0%
2008 5.0% -16.7%
2009 8.0% +60.0%
2010 8.0% +0.0%
2011 9.0% +12.5%
2012 4.0% -55.6%
2013 10.0% +150.0%
2014 63.0% +530.0%
2015 60.0% -4.8%
2016 19.0% -68.3%
2017 14.0% -26.3%
2018 23.0% +64.3%
2019 41.0% +78.3%
2020 25.0% -39.0%
2021 9.0% -64.0%
2022 29.0% +222.2%
2023 40.0% +37.9%
2024 39.0% -2.5%

Mauritania compared with similar countries

  • Mauritania's 39.0% is below the median for lower middle income countries, which is 83.5%, 47% of the median. (32 countries reporting)
  • Mauritania's 39.0% is below the median for Sub-Saharan Africa, which is 82.0%, 48% of the median. (41 countries reporting)

Biggest year-on-year movements

Years where Antiretroviral therapy coverage for PMTCT in Mauritania changed far more than this series normally does. A large move can be a real event or a change in how the figure was measured — the source note below says who published it.

YearChange FromTo
2014 +530.0% 10.0% 63.0%

Averages by decade

DecadeAverage LowestHighest Years
2000s 2.0% 0.0% 8.0% 10
2010s 25.1% 4.0% 63.0% 10
2020s 28.4% 9.0% 40.0% 5

Countries ranked near Mauritania

  1. 70 Congo 42.0% compare
  2. 70 Costa Rica 42.0% compare
  3. 70 Honduras 42.0% compare
  4. 74 Djibouti 38.0% compare
  5. 75 Democratic Republic of Congo 32.0% compare
  6. 75 Tunisia 32.0% compare

See the full ranking of 99 places →

More health data for Mauritania

All data for Mauritania →

Frequently asked questions

What is antiretroviral therapy coverage for pmtct in Mauritania?
Antiretroviral therapy coverage for pmtct in Mauritania was 39.0% in 2024, according to UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS).
What is the highest antiretroviral therapy coverage for pmtct recorded in Mauritania?
The highest recorded value was 63.0% in 2014.
What is the lowest antiretroviral therapy coverage for pmtct recorded in Mauritania?
The lowest recorded value was 0.0% in 2000.
How does Mauritania rank for antiretroviral therapy coverage for pmtct?
Mauritania ranks 73rd out of 84 countries with data for 2024.
Is antiretroviral therapy coverage for pmtct rising or falling in Mauritania?
Over the last ten years it is down 38.1%. The long-run trend across the full record is volatile.
Where does this Mauritania data come from?
The figures come from UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS), published as part of Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV). Statizoid updates them automatically from the source API.

Download this data

CSV · JSON — 25 observations, free to reuse under CC BY 4.0 (World Bank Open Data).

Share, cite or embed this page

Cite this page

Antiretroviral therapy coverage for PMTCT in Mauritania. Statizoid, drawing on UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS). Retrieved 18 September 2026, from https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/mauritania/

Embed or link this data

Paste this into a page to link back to these figures. The data itself is free to reuse under CC BY 4.0 (World Bank Open Data); please keep the attribution.

<a href="https://health.statizoid.com/stat/antiretroviral-therapy-coverage-for-pmtct-percent-of-pregnant-women-living-with-hiv/mauritania/">Antiretroviral therapy coverage for PMTCT in Mauritania</a> — Statizoid

About this data

Indicator
Antiretroviral therapy coverage for PMTCT (% of pregnant women living with HIV)
Unit
% of pregnant women living with HIV
Source
UNAIDS estimates, Joint United Nations Programme on HIV/AIDS (UNAIDS)
Licence
CC BY 4.0 (World Bank Open Data)
Coverage
99 places, 2,393 data points, 2000–2024
Last refreshed

Percentage of pregnant women with HIV who receive antiretroviral medicine for prevention of mother-to-child transmission (PMTCT).